Literature DB >> 26352422

Rituximab maintenance in follicular lymphoma.

Paul M Barr1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26352422

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

1.  Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.

Authors:  Amy K Erbe; Wei Wang; Lakeesha Carmichael; Anna Hoefges; Bartosz Grzywacz; Patrick K Reville; Erik A Ranheim; Jacquelyn A Hank; KyungMann Kim; Songwon Seo; Eneida A Mendonca; Yiqiang Song; Vaishalee P Kenkre; Fangxin Hong; Randy D Gascoyne; Elisabeth Paietta; Sandra J Horning; Jeffrey S Miller; Brad Kahl; Paul M Sondel
Journal:  J Immunother Cancer       Date:  2019-03-12       Impact factor: 13.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.